Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131435) titled 'A Multicenter, Prospective, Observational, Real-World Registry Study of Cenobamate in the Treatment of Focal Epilepsy' on Sept. 2.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
epilepsy
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-03
Target Sample Size: Cenobamate group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341189
Disclaimer: Curated by HT Syndication....